Your session is about to expire
← Back to Search
Counseling for Advanced Cancer
N/A
Waitlist Available
Led By David Bekelman, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adults ages > or = 18 years of age
Have stage III/IV cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up start of study to end of study, up to 12 months
Awards & highlights
Study Summary
This trial will study whether patient navigators can help improve palliative care for patients with life-limiting illness.
Who is the study for?
This trial is for Latino adults over 18 with advanced stage III/IV cancer, who are not in hospice care but are receiving treatment. Participants must be experiencing a moderate level of distress or show signs of depression or anxiety.Check my eligibility
What is being tested?
The study tests the effectiveness of patient navigators and psychosocial interventions to improve palliative care, which focuses on symptom management and quality of life for patients with serious illnesses.See study design
What are the potential side effects?
Since the intervention involves counseling rather than medication, typical medical side effects are not expected. However, discussing sensitive issues may cause temporary emotional discomfort.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
My cancer is at an advanced stage (III or IV).
Select...
I am currently seeking or undergoing treatment for my cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ start of study to end of study, up to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~start of study to end of study, up to 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility of Completion: number of patients that complete the study
Feasibility of Recruitment: number of patients that are eligible to participate
Secondary outcome measures
Process Measure Assessment
Other outcome measures
Anxiety Assessment
Depression Assessment
FACT-G Quality of Life Assessment
+3 moreSide effects data
From 2020 Phase 4 trial • 80 Patients • NCT0327678010%
Vivid Dreams/Nightmares
10%
Vomiting
7%
Nausea
5%
Headache
5%
Throat Irritation
5%
Rash
5%
Excessive Sneezing
5%
Ear Pain
2%
Nasal Tingling
2%
Burning Mouth/Throat
2%
Nasal Drainage
2%
Watering Eyes
2%
Tooth Pain
2%
Excessive Coughing
2%
Nasal Burning
2%
Jitteriness
2%
Nicotine Dosage Too Strong
2%
Undisclosed Virus
2%
Nasal Irritation
2%
Nasal Blistering
2%
Upper Respiratory Infection
2%
Increased Heart Rate
100%
80%
60%
40%
20%
0%
Study treatment Arm
In Vivo
Standard of Care
Trial Design
1Treatment groups
Experimental Treatment
Group I: Stepped InterventionsExperimental Treatment1 Intervention
Patient navigation intervention, plus various psychosocial interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Counseling
2017
Completed Phase 4
~1970
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,732 Previous Clinical Trials
2,143,533 Total Patients Enrolled
David Bekelman, MDPrincipal InvestigatorUniversity of Colorado, Denver
Stacy Fischer, MDPrincipal InvestigatorUniversity of Colorado, Denver
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experiment currently enrolling participants?
"Clinicaltrials.gov has reported that this medical trial is not currently seeking enrolment, despite being initially established on January 23rd 2018 and last updated on August 22nd 2022. Nevertheless, there are 2478 alternative trials actively recruiting participants at the present time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger